Rachel Capone, MSHS
Advertisement
Rachel Capone, MSHS, is a regulatory affairs manager, Syner-G BioPharma Group.
Articles by Rachel Capone, MSHS
Advertisement
Latest Updated Articles
Unlocking the Benefits of FDA’s Orphan Drug DesignationAugust 22nd 2023
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
3
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
4
Survodutide Meets CV Safety End Point in SYNCHRONIZE-CVOT
5